These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32984899)

  • 1. Vancomycin prophylaxis in paediatric patients following cardiac surgery: a retrospective evaluation of trough levels and associated variables.
    Vallesi L; Fragasso T; Benegni S; Insom G; Di Chiara L; Corsetti T; Ricci Z
    Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):667-673. PubMed ID: 32984899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations.
    Thomas CA; Picone A; Menon S; Willis BC
    Pharmacotherapy; 2017 Nov; 37(11):1341-1346. PubMed ID: 28833385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of vancomycin therapeutic usage and trough levels monitoring.
    Kabbara WK; El-Khoury G; Chamas NR
    J Infect Dev Ctries; 2018 Nov; 12(11):978-984. PubMed ID: 32012127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoxitin Prophylaxis During Pediatric Cardiac Surgery: Retrospective Exploration of Postoperative Trough Levels.
    Ricci Z; Benegni S; Cies JJ; Marinari E; Haiberger R; Garisto C; Cairoli S; Di Chiara L; Goffredo B
    Pediatr Infect Dis J; 2019 May; 38(5):484-489. PubMed ID: 30169486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin.
    Buckel WR; Ghobrial S; Tamma PD; Milstone AM; Zhao Y; Hsu AJ
    Paediatr Drugs; 2017 Feb; 19(1):43-51. PubMed ID: 27873214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of empiric vancomycin dosing in a neonatal population.
    Radu L; Bengry T; Akierman A; Alshaikh B; Yusuf K; Dersch-Mills D
    J Perinatol; 2018 Dec; 38(12):1702-1707. PubMed ID: 30341404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin.
    Kheir MM; Tan TL; Azboy I; Tan DD; Parvizi J
    Clin Orthop Relat Res; 2017 Jul; 475(7):1767-1774. PubMed ID: 28401341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit population.
    Chung E; Lee SE; Abraham T; Saad NN; Gad A
    J Neonatal Perinatal Med; 2019; 12(1):21-27. PubMed ID: 30149480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
    Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
    Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin concentrations during cardiopulmonary bypass in pediatric cardiac surgery: a prospective study.
    Ferrari F; Benegni S; Marinari E; Haiberger R; Garisto C; Rizza A; Giorni C; Quattrone MG; Arpicco S; Muntoni E; Milla P; Ricci Z
    Perfusion; 2022 Sep; 37(6):553-561. PubMed ID: 33789546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Pediatric-Specific Vancomycin Dosing Guidelines: A Quality Improvement Initiative.
    Miloslavsky M; Galler MF; Moawad I; Actis J; Cummings BM; El Saleeby CM
    Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Vancomycin Dose for Recommended Trough Concentrations in Pediatric Patients With Cystic Fibrosis.
    Amin RW; Guttmann RP; Harris QR; Thomas JW
    J Clin Pharmacol; 2018 May; 58(5):662-665. PubMed ID: 29319843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
    Hartman SJF; Orriëns LB; Zwaag SM; Poel T; de Hoop M; de Wildt SN
    Paediatr Drugs; 2020 Aug; 22(4):433-444. PubMed ID: 32507958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty.
    Courtney PM; Melnic CM; Zimmer Z; Anari J; Lee GC
    Clin Orthop Relat Res; 2015 Jul; 473(7):2197-203. PubMed ID: 25421958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review.
    Tkachuk S; Collins K; Ensom MHH
    Paediatr Drugs; 2018 Apr; 20(2):153-164. PubMed ID: 29344778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Prophylaxis for Open Chest Management After Pediatric Cardiac Surgery.
    Hatachi T; Sofue T; Ito Y; Inata Y; Shimizu Y; Hasegawa M; Kugo Y; Yamauchi S; Iwai S; Takeuchi M
    Pediatr Crit Care Med; 2019 Sep; 20(9):801-808. PubMed ID: 31107376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.